Lonza

Lonza

featured image of Lonza Boosts Microbial Production with Major Expansion!

Lonza Boosts Microbial Production with Major Expansion!

BIOT

🌍 Lonza expands its microbial manufacturing facility in Visp, Switzerland, adding two 4,000L fermenters and a new GMP license! ✅📈🔧

featured image of 2024's Top CDMOs: Leaders and Challenges Ahead!

2024’s Top CDMOs: Leaders and Challenges Ahead!

BIOT

**Excerpt:** Discover the top 10 CDMOs for 2024! 🌟 Lonza, Thermo Fisher, and Catalent lead the way amidst industry challenges. 📈⚠️

featured image of Lonza Partners with Acumen for Alzheimer's Breakthrough

Lonza Partners with Acumen for Alzheimer’s Breakthrough

BIOT

📰 Lonza teams up with Acumen to make sabirnetug, a groundbreaking Alzheimer's therapy, at their New Hampshire facility. 👥 🧪 Sabirnetug targets toxic amyloid beta oligomers, offering hope in the fight against Alzheimer's. 💡 ⏩ Exciting collaboration to speed up Alzheimer's treatment development. Lonza Acumen AlzheimersTherapy Sabirnetug

featured image of Lonza Revolutionizes Respiratory Treatment with Advanced Pulmonary Delivery Services

Lonza Revolutionizes Respiratory Treatment with Advanced Pulmonary Delivery Services

BIOT

📢 Lonza expands service offering for spray-dried biologics for pulmonary delivery, improving respiratory therapies and patient access. 🌬️💊🌍💪

featured image of Lonza Acquires Genentech's $12B Biologics Site

Lonza Acquires Genentech’s $12B Biologics Site

BIOT

📢 Lonza buys Genentech's CA biologics manufacturing site for $1.2B, boosting production capabilities for next-gen therapies. 🏭

featured image of Revolutionary Partnership Speeds Up mRNA Analysis!

Revolutionary Partnership Speeds Up mRNA Analysis!

BIOT

🧪📈 Lonza and Oxford Nanopore join forces to revolutionize mRNA analysis in the fast-paced biotech sector. Exciting times ahead!

featured image of Revolutionary Partnership to Enhance mRNA Therapeutics

Revolutionary Partnership to Enhance mRNA Therapeutics

BIOT

📢 Lonza and Oxford Nanopore collaborate to advance mRNA Therapeutics! This partnership aims to improve mRNA product analysis 👥🧬💉

featured image of Lonza's Upcoming Approvals Will Revolutionize CGT Biz in 2024

Lonza’s Upcoming Approvals Will Revolutionize CGT Biz in 2024

BIOT

💼Lonza is looking to strengthen its cell and gene therapy business through upcoming approvals in 2024. 🌟🔬💉💪📈🔒💼🌐

featured image of Lonza shuts down Swiss manufacturing site cutting 190 jobs

Lonza shuts down Swiss manufacturing site cutting 190 jobs

BIOT

📢 Lonza is decommissioning its mammalian manufacturing site in Visp, Switzerland, after 30 years of operation. 🏭✅ This decision is driven by market dynamics and the need for flexibility. ❌ However, Lonza will focus on other sites and genecell therapies. 😔 Around 190 jobs will be lost.